Eton Pharmaceuticals (ETON) Gross Margin (2019 - 2025)
Eton Pharmaceuticals (ETON) reported Gross Margin of 61.56% for Q4 2025, up 595.0% on a YoY basis from 8.86% in Q4 2024, and up 76.0% sequentially from 34.97% in Q3 2025.
Eton Pharmaceuticals (ETON) Gross Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of Gross Margin data on file, last reported at 61.56% in Q4 2025.
- For the quarter ending Q4 2025, Gross Margin rose 595.0% year-over-year to 61.56%; the trailing twelve-month figure through Dec 2025 stood at 53.46% (down 655.0% YoY), and the FY2025 full-year result was 53.46%, down 655.0% from the prior year.
- Gross Margin grew to 61.56% in Q4 2025, from 34.97% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 94.33% in Q2 2021 to a low of 12.18% in Q4 2023.
- A 5-year average of 61.78% and a median of 62.33% in 2023 frame the typical range for Gross Margin.
- Peak annual rise in Gross Margin reached 13433 bps in 2021, while the deepest fall reached 720611 bps in 2021.
- Tracing ETON's Gross Margin over 5 years: stood at 93.89% in 2021, then decreased by 20 bps to 74.84% in 2022, then tumbled by 84 bps to 12.18% in 2023, then jumped by 356 bps to 55.6% in 2024, then advanced by 11 bps to 61.56% in 2025.
- Business Quant data shows ETON's Gross Margin at 61.56% in Q4 2025, 34.97% in Q3 2025, and 63.0% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 61.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.56% |
| Sep 30, 2025 | 34.97% |
| Jun 30, 2025 | 63.00% |
| Mar 31, 2025 | 57.06% |
| Dec 31, 2024 | 55.60% |
| Sep 30, 2024 | 61.04% |
| Jun 30, 2024 | 62.00% |
| Mar 31, 2024 | 62.85% |
| Dec 31, 2023 | 12.18% |
| Sep 30, 2023 | 62.65% |
| Jun 30, 2023 | 80.70% |
| Mar 31, 2023 | 63.08% |
| Dec 31, 2022 | 74.84% |
| Sep 30, 2022 | 40.36% |
| Jun 30, 2022 | 92.26% |
| Mar 31, 2022 | 60.98% |
| Dec 31, 2021 | 93.89% |
| Sep 30, 2021 | 15.61% |
| Jun 30, 2021 | 94.33% |
| Mar 31, 2021 | 86.64% |